Quarterly Information (Unaudited)

12 Months Ended

Dec. 30, 2017

Note 18 – Quarterly Information (Unaudited)

The following tables present certain quarterly financial data:

		Quarters ended
		April 1,		July 1,		September 30,		December 30,
		2017 (2)		2017 (2)		2017 (2)		2017
Net sales		$	2,922,948	$	3,059,458	$	3,161,083	$	3,318,054
Gross profit			822,920		839,173		836,054		900,956
Operating income			193,968		210,662		213,548		241,191
Net income			150,253		149,582		150,948		8,510

Amounts attributable to
	Henry Schein, Inc.:
Net income (loss)			140,748		136,055		138,031		(8,535)

Earnings (loss) per share attributable to
	Henry Schein, Inc.:

	Basic	$	0.89	$	0.86	$	0.88	$	(0.06)
	Diluted		0.88		0.86		0.87		(0.06)
		Quarters ended
		March 26,		June 25,		September 24,		December 31,
		2016 (1) (2)		2016 (1) (2)		2016 (1) (2)		2016 (1) (2)
Net sales		$	2,712,956	$	2,872,630	$	2,865,148	$	3,120,934
Gross profit			777,842		801,469		787,675		859,487
Restructuring costs			4,058		20,383		5,370		16,080
Operating income			176,194		180,677		200,721		213,982
Net income			124,533		133,098		145,291		153,473

Amounts attributable to
	Henry Schein, Inc.:
Net income			113,752		120,097		133,713		139,216

Earnings per share attributable to
	Henry Schein, Inc.:

	Basic	$	0.70	$	0.74	$	0.83	$	0.88
	Diluted		0.69		0.73		0.82		0.86

(1)	See Note 10 - "Plans of Restructuring" for details of the restructuring costs incurred during the fiscal year of 2016.

(2)	See Item 5 - "Purchases of Equity Securities by the Issuer" for details of the 2-for-1 split of our common stock, during the third quarter of 2017.

We experience fluctuations in quarterly financial results. As a result, we may fail to meet or exceed the expectations of securities analysts and investors, which could cause our stock price to decline.

Our business is subject to seasonal and other quarterly fluctuations. Revenues and profitability generally have been higher in the third and fourth quarters due to the timing of sales of seasonal products (including influenza vaccine, equipment and software products), purchasing patterns of office-based health care practitioners and year-end promotions. Revenues and profitability generally have been lower in the first quarter, primarily due to increased sales in the prior two quarters. We expect our historical seasonality of sales to continue in the foreseeable future. Quarterly results may also be materially adversely affected by a variety of other factors, including:

• timing and amount of sales and marketing expenditures;

• timing of pricing changes offered by our suppliers;

• timing of the introduction of new products and services by our suppliers;

• timing of the release of upgrades and enhancements to our technology-related products and services;

• changes in or availability of supplier contracts or rebate programs;

• supplier rebates based upon attaining certain growth goals;

• changes in the way suppliers introduce or deliver products to market;

• costs of developing new applications and services;

• our ability to correctly identify customer needs and preferences and predict future needs and preferences;

• uncertainties regarding potential significant breaches of data security or disruptions of our information technology systems;

• unexpected regulatory actions, or government regulation generally;

• exclusivity requirements with certain suppliers may prohibit us from distributing competitive products manufactured by other suppliers;

• loss of sales representatives;

• costs related to acquisitions and/or integrations of technologies or businesses;

• costs associated with our self-insured medical and dental insurance programs;

• general market and economic conditions, as well as those specific to the health care industry and related industries;

• our success in establishing or maintaining business relationships;

• unexpected difficulties in developing and manufacturing products;

• product demand and availability or recalls by manufacturers;

• exposure to product liability and other claims in the event that the use of the products we sell results in injury;

• increases in shipping costs or service issues with our third-party shippers;

• fluctuations in the value of foreign currencies;

• restructuring costs;

• the adoption or repeal of legislation;

• changes in accounting principles; and

• litigation or regulatory judgements, expenses or settlements

Any change in one or more of these or other factors could cause our annual or quarterly financial results to fluctuate. If our financial results do not meet market expectations, our stock price may decline.